Evidence map›Paper›PMID 32595833›Full record

ArticleOncotarget2020

Lineage-restricted sympathoadrenal progenitors confer neuroblastoma origin and its tumorigenicity.

Chia-Lung Yang, André Serra-Roma, Marco Gualandi, Nicole Bodmer, Felix Niggli, Johannes Hubertus Schulte, Peter Karl Bode, Olga Shakhova

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. CRISPR/Cas9-mediatedFrontiers in physiology · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. MYCN Function in Neuroblastoma Development.Frontiers in oncology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Chia-Lung YangDepartment of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.
André Serra-RomaDepartment of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.
Marco GualandiDepartment of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.
Nicole BodmerDepartment of Oncology, Children Hospital of Zürich, Zürich, Switzerland.
Felix NiggliDepartment of Oncology, Children Hospital of Zürich, Zürich, Switzerland.
Johannes Hubertus SchulteDepartment of Pediatric Hematology, Oncology and SCT, Charité University Hospital, Berlin, Germany.
Peter Karl BodeDepartment of Surgical Pathology, University Hospital Zürich, Zürich, Switzerland.
Olga ShakhovaDepartment of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.
University Hospital of Zurich · CHUniversity Children's Hospital Zurich · CHCharité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroblastoma (NB) is the most common cancer in infants and it accounts for six percent of all pediatric malignancies. There are several hypotheses proposed on the origins of NB. While there is little genetic evidence to support this, the prevailing model is that NB originates from neural crest stem cells (NCSCs). Utilizing

Indexed as

neural crest stem cellsneuroblastomasox geness

Identifiers

PMID32595833
PMCPMC7299536
OpenAlexW3036140790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.